State of New York
|
1-10113
|
11-0853640
|
(State of Other Jurisdiction
|
(Commission File Number)
|
(I.R.S. Employer
|
of Incorporation)
|
Identification Number)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
|
Item 5.02
|
Departure of Directors or Principal Officers; Election of Directors;
|
Name
|
Title
|
Bonus Award
|
||||
Robert B. Jones
|
President and Chief Executive Officer
|
$ | 138,800 | |||
Peter A. Clemens
|
Senior Vice President and Chief Financial Officer
|
$ | 96,500 | |||
Albert W. Brzeczko
|
Vice President, Technical Affairs
|
$ | 41,100 | |||
Robert A. Seiser
|
Vice President, Controller and Treasurer
|
$ | 33,500 | |||
James F. Emigh
|
Vice President, Corporate Development
|
$ | 26,300 | |||
J. Bradley Rivet
|
Vice President, Marketing
|
$ | 6,200 |
ACURA PHARMACEUTICALS, INC.
|
||
By:
|
/s/ Peter A. Clemens
|
|
Peter A. Clemens
|
||
Senior Vice President & Chief Financial Officer
|